147 related articles for article (PubMed ID: 15046942)
1. Collagenous matrices as release carriers of exogenous growth factors.
Kanematsu A; Yamamoto S; Ozeki M; Noguchi T; Kanatani I; Ogawa O; Tabata Y
Biomaterials; 2004 Aug; 25(18):4513-20. PubMed ID: 15046942
[TBL] [Abstract][Full Text] [Related]
2. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
Nillesen ST; Geutjes PJ; Wismans R; Schalkwijk J; Daamen WF; van Kuppevelt TH
Biomaterials; 2007 Feb; 28(6):1123-31. PubMed ID: 17113636
[TBL] [Abstract][Full Text] [Related]
3. Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor.
Kanematsu A; Yamamoto S; Noguchi T; Ozeki M; Tabata Y; Ogawa O
J Urol; 2003 Oct; 170(4 Pt 2):1633-8. PubMed ID: 14501679
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparative evaluation of recombinant growth factors for tissue engineering of bladder in patients with neurogenic bladder.
Yang B; Zhou L; Peng B; Sun Z; Dai Y; Zheng J
J Surg Res; 2014 Jan; 186(1):63-72. PubMed ID: 24095026
[TBL] [Abstract][Full Text] [Related]
5. Effect of several growth factors on canine flexor tendon fibroblast proliferation and collagen synthesis in vitro.
Thomopoulos S; Harwood FL; Silva MJ; Amiel D; Gelberman RH
J Hand Surg Am; 2005 May; 30(3):441-7. PubMed ID: 15925149
[TBL] [Abstract][Full Text] [Related]
6. Type I collagen can function as a reservoir of basic fibroblast growth factor.
Kanematsu A; Marui A; Yamamoto S; Ozeki M; Hirano Y; Yamamoto M; Ogawa O; Komeda M; Tabata Y
J Control Release; 2004 Sep; 99(2):281-92. PubMed ID: 15380637
[TBL] [Abstract][Full Text] [Related]
7. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices.
Yao C; Roderfeld M; Rath T; Roeb E; Bernhagen J; Steffens G
Biomaterials; 2006 Mar; 27(8):1608-16. PubMed ID: 16183114
[TBL] [Abstract][Full Text] [Related]
8. Influence of modified extracellular matrices on TI6AL4V implants on binding and release of VEGF.
Wolf-Brandstetter C; Lode A; Hanke T; Scharnweber D; Worch H
J Biomed Mater Res A; 2006 Dec; 79(4):882-94. PubMed ID: 16941591
[TBL] [Abstract][Full Text] [Related]
9. Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2).
Princz MA; Sheardown H
J Biomater Sci Polym Ed; 2008; 19(9):1201-18. PubMed ID: 18727861
[TBL] [Abstract][Full Text] [Related]
10. Gel matrix vehicles for growth factor application in nerve gap injuries repaired with tubes: a comparison of biomatrix, collagen, and methylcellulose.
Wells MR; Kraus K; Batter DK; Blunt DG; Weremowitz J; Lynch SE; Antoniades HN; Hansson HA
Exp Neurol; 1997 Aug; 146(2):395-402. PubMed ID: 9270050
[TBL] [Abstract][Full Text] [Related]
11. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
12. Sustained release and activation of the growth factor basic fibroblast growth factor from loaded scaffolds in heart valve tissue engineering.
Somers P; Narine K; De Somer F; de Vos F; V Nooten G
Growth Factors; 2008 Oct; 26(5):293-9. PubMed ID: 18651289
[TBL] [Abstract][Full Text] [Related]
13. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization.
Freeman I; Cohen S
Biomaterials; 2009 Apr; 30(11):2122-31. PubMed ID: 19152972
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder.
Kikuno N; Kawamoto K; Hirata H; Vejdani K; Kawakami K; Fandel T; Nunes L; Urakami S; Shiina H; Igawa M; Tanagho E; Dahiya R
BJU Int; 2009 May; 103(10):1424-8. PubMed ID: 18990142
[TBL] [Abstract][Full Text] [Related]
15. Promotion of skin regeneration in diabetic rats by electrospun core-sheath fibers loaded with basic fibroblast growth factor.
Yang Y; Xia T; Zhi W; Wei L; Weng J; Zhang C; Li X
Biomaterials; 2011 Jun; 32(18):4243-54. PubMed ID: 21402405
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 2-functionalized collagen matrices for skeletal muscle tissue engineering.
Yun YR; Lee S; Jeon E; Kang W; Kim KH; Kim HW; Jang JH
Biotechnol Lett; 2012 Apr; 34(4):771-8. PubMed ID: 22160363
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of bioactive factors in bladder submucosa matrix.
Chun SY; Lim GJ; Kwon TG; Kwak EK; Kim BW; Atala A; Yoo JJ
Biomaterials; 2007 Oct; 28(29):4251-6. PubMed ID: 17617449
[TBL] [Abstract][Full Text] [Related]
18. The effect of cross-linking of collagen matrices on their angiogenic capability.
Yao C; Markowicz M; Pallua N; Noah EM; Steffens G
Biomaterials; 2008 Jan; 29(1):66-74. PubMed ID: 17935778
[TBL] [Abstract][Full Text] [Related]
19. Controlled growth factor release from synthetic extracellular matrices.
Lee KY; Peters MC; Anderson KW; Mooney DJ
Nature; 2000 Dec 21-28; 408(6815):998-1000. PubMed ID: 11140690
[TBL] [Abstract][Full Text] [Related]
20. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.
Lee SH; Shin H
Adv Drug Deliv Rev; 2007 May; 59(4-5):339-59. PubMed ID: 17499384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
